Analysis Demonstrates Gastric Banding is a Safe and Cost-Effective Weight-Loss Surgery Procedure

A new study published in the peer-reviewed journal Surgery for Obesity and Related Diseases,the Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, found that the cost of a gastric banding weight-loss surgery procedure, such as Allergan's Lap-Band® Adjustable Gastric Banding System, was offset by reductions in obesity-related medical costs within 2.25 years for surgery eligible patients with diabetes, and within four years of the procedure for all surgery eligible patients.

Adjustable gastric banding is generally indicated for weight reduction for patients with obesity, with a Body Mass Index (BMI) of at least 40 kg/m2 or a BMI of at least 30 kg/m2 with one or more obesity related comorbid conditions.

Exercise and behavior modification
Lap-Band® It is indicated for use in adult patients who have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives.

Critical effect gastric banding
The study published in the Surgery for Obesity and Related Diseases evaluated healthcare claims data from 7,310 patients who had undergone gastric banding compared to claims from a matched control group of 7,306 surgery eligible obese individuals who did not have weight-loss surgery, for the purpose of quantifying the potential savings of gastric banding. The study found that while post-surgery medical costs for the gastric banding group declined slightly, medical costs for the control group continued to rise, thus resulting in significant savings for the banding sample. These findings underscore the critical effect gastric banding has on containing healthcare costs among the target population.

Obese patients with diabetes
"Although the gastric banding procedure is associated with upfront costs, our analysis shows that those costs are recovered in a relatively short period of time, particularly for obese patients with diabetes," said study lead author Eric A. Finkelstein, Ph.D., of Duke University and Duke-NUS Graduate Medical School in Singapore. "Although the potential for cost-savings should not drive coverage decisions, some insurance providers are hesitant to cover the costs of bariatric procedures for fear they will break the bank. These results may allay some of those concerns," Finkelstein said.

Life-threatening co-morbid conditions
Currently, one in three American adults is obese.[1] Due to increased medical expenditures, absenteeism, and presenteeism (reduced on the job productivity due to health reasons), obesity now costs U.S. businesses roughly $70 billion per year.[2] The total medical bill for the nation as a result of obesity is now projected at $147 billion per year, or nearly 10% of all medical expenses in the United States.[3] This figure is projected to reach 16-18 percent of all U.S. healthcare costs in the next 20 years.[4] Given its known correlation to life-threatening co-morbid conditions, such as heart disease, stroke, Type 2 diabetes, high blood pressure, sleep apnea and even premature death, obesity is a disease that requires medical treatment. Furthermore, medical research has found that if left untreated those individuals who are currently obese will likely remain obese,[5] highlighting the unmet clinical need among obese patients for the availability of and reimbursement for effective treatment options.

Reduction of obesity-related comorbid conditions
"This study is consistent with the vast findings from the published literature that support gastric banding is an effective and safe weight-loss surgery procedure that can produce sustained weight loss, ultimately resulting in reduction of obesity-related comorbid conditions and medical costs," said Frederick Beddingfield, M.D., Allergan's Vice President of Clinical Research and Development. "Research of this kind is integral in our efforts as a company to ensure appropriate access to and affordability for the LAP-BAND® System procedure for patients across the country."

[1] CDC: National Center for Health Statistics. NCHS Data on Obesity. Last accessed March 22, 2010.
[2] Finkelstein et al. The Costs of Obesity in the Workplace. Journal of Occupational & Environmental Medicine. 2010; 52(10):971-976.
[3] Finkelstein et al.Health Affairs 28, no. 5 (2009): w822—w831.
[4] Wang Y, Beydoun MA, Liang L, et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity. Obesity October 2008;16(10):2323-2330.
[5] Kuczmarski MD, Prevelance of Overweight and Weight Gain in the United States. Am J Clin Nutr 1992; 55:495S-502S.

Views: 34

Tags: Allergan, BMI, Excerise, bariatric, behavior, gastric, insurance, lap-band, metaboloc, obesity, More…obesity-related, patients


You need to be a member of The Diabetes Challenge to add comments!

Join The Diabetes Challenge


About Diabetes Mellitus

Diabetes Mellitus (DM) is a common metabolic disorder associated with abnormally high blood sugar levels. Diabetes is classified as either type 1 (T1DM), which is characterized by severely diminished insulin production, or type 2 (T2DM), which is characterized by moderately diminished insulin production in conjunction with insulin resistance (insensitivity of the tissues of the body to insulin). Insulin is a hormone that regulates blood glucose levels. Diabetes can seriously impair overall quality of life and may lead to multiple complications including heart disease, stroke, and kidney failure. According to the International Diabetes Federation, more than 245 million people have diabetes, with type 2 diabetes being the most prevalent.

The Diabetes Challenge is now on Twitter! Join us today so you can stay up to date with our most current blog articles! Click here to follow us!